Abstract:Background We have previously reported that C-peptide exerts preventive and therapeutic effects on diabetic neuropathy in type 1 diabetic BB/Wor-rats and that it prevents duration-dependent hippocampal apoptosis in the same animal model. In the present study, we examined human neuroblastoma SH-SY5Y cells to examine whether C-peptide stimulates cell proliferation/neurite outgrowth and whether it has antiapoptotic effects.Methods For neurite outgrowth, C-peptide and/or insulin or IGF-1. Neurites were visualized with NF-L antibody and measured morphometrically. Cell numbers were determined using an electronic cell counter. Scrambled C-peptide was used as a negative SH-SY5Y cells were incubated with control. For assessment of apoptosis, 100 mM glucose for 24 h, and the effects of C-peptide and/or insulin or IGF-1 were examined. Apoptosis was demonstrated by transferase-mediated dUTP nick-end labeling (TUNEL)/4,6-diamidino-2-phenylindole (DAPI) stainings, flow cytometry and changes in the expression of Bcl(2). Activation of insulin signaling intermediaries was determined by Western blots. Translocation of NF-kappaB was demonstrated immunocytochemically.Results C-peptide but not scrambled C-peptide stimulated cell proliferation and neurite outgrowth. in the presence of 4 nM insulin, 3 nM C-peptide significantly increased autophosphorylation of the insulin receptor (IR) but not that of the insulin-like growth factor 1 receptor (IGF-1R). It stimulated phosphoinositide 3-kinase (PI-3 kinase) and p38 mitogen-activated protein (MAP) kinase activation, enhanced the expression and translocation of nuclear factor-kappaB (NF-kappaB), promoted the expression of Bcl(2) and reduced c-jun N-terminal kinase (JNK) phosphorylation in excess of that of insulin alone.Conclusions C-peptide in the presence of insulin exerts synergistic effects on cell proliferation, neurite outgrowth and has in the presence of insulin an antiapoptotic effect on high glucose-induced apoptosis but less so on hyperosmolar-induced apoptosis. These effects are likely to be mediated via interactions with the insulin signaling pathway. Copyright (C) 2003 John Wiley Sons, Ltd.

Mutated Recombinant Human Glucagon-Like Peptide-1 Induces Differentiation of Pc12 Cells

Mutated Recombinant Human Glucagon-like Peptide-1 Protects SH-SY5Y Cells from Apoptosis Induced by Glutamate

Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-β peptide (1–42)

A Mutated Glucagon-Like Peptide-1 with Improved Glucose-Lowering Activity in Diabetic Mice

Glucagon-like peptide-1 attenuated carhoxymethyl lysine induced neuronal apoptosis via peroxisome proliferation activated receptor-

The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration

Glial Cell Line-Derived Neurotrophic Factor Promotes Survival and Induces Differentiation Through the Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathway Respectively in PC12 Cells

Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

Glucagon-Like Peptide-1 Analog-Mediated Protection Against Cholesterol-Induced Apoptosis Via Mammalian Target Of Rapamycin Activation In Pancreatic Beta Tc-6 Cells

Expression, Purification, and C-terminal Site-Specific PEGylation of Cysteine-Mutated Glucagon-Like Peptide-1

Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.

A GLP-2 Analogue Protects SH-SY5Y and Neuro-2a Cells Against Mitochondrial Damage, Autophagy Impairments and Apoptosis in a Parkinson Model

Glucagon‐like Peptide‐1 Cleavage Product GLP‐1 (9‐36) Amide Enhances Hippocampal Long‐term Synaptic Plasticity in Correlation with Suppression of Kv4.2 Expression and Eef2 Phosphorylation

Glucagon-like Peptide-1 Improves Proliferation and Differentiation of Endothelial Progenitor Cells Via Upregulating VEGF Generation.

Combination of GLP-1 Receptor Activation and Glucagon Blockage Promotes Pancreatic Β-Cell Regeneration in Situ in Type 1 Diabetic Mice

Glucagon-like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice.

Addition of A Cysteine to Glucagon-Like Peptide-1 (Glp-1) Conjugates Glp-1 to Albumin in Serum and Prolongs Glp-1 Action in Vivo

Effect of Glucagon Like Peptide-1 on Proliferation and Differentiation of Endothelial Progenitor Cells and Its Mechanism

GLP-1 Analog Liraglutide Enhances Proinsulin Processing in Pancreatic Β-Cells Via a PKA-dependent Pathway.

C-peptide Enhances Insulin-Mediated Cell Growth and Protection Against High Glucose-Induced Apoptosis in SH-SY5Y Cells.

A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis.